Citation: Si Ha, Jiacheng Zhu, Hua Xiang, Guoshun Luo. Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives[J]. Chinese Chemical Letters, ;2024, 35(8): 109192. doi: 10.1016/j.cclet.2023.109192 shu

Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives

Si Ha ¹ ,
Jiacheng Zhu ¹ ,
Hua Xiang ^*, ,
Guoshun Luo ^*,

State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China

xianghua@cpu.edu.cn

gsluo@cpu.edu.cn

Received Date: 19 August 2023
Revised Date: 6 October 2023
Accepted Date: 10 October 2023
Available Online: 13 October 2023

Figures(20)

Small molecule inhibitors have dominated the pharmaceutical landscape for a long time as the primary therapeutic paradigm targeting pathogenic proteins. However, their efficacy heavily relies on the amino acid composition and spatial constitution of proteins, rendering them susceptible to drug resistance and failing to target undruggable proteins. In recent years, the advent of targeted protein degradation (TPD) technology has captured substantial attention from both industry and academia. Employing an event-driven mode, TPD offers a novel approach to eliminate pathogenic proteins by promoting their degradation, thus circumventing the limitations associated with traditional small molecule inhibitors. Hydrophobic tag tethering degrader (HyTTD) technology represents one such TPD approach that is currently in the burgeoning stage. HyTTDs employ endogenous protein degradation systems to induce the degradation of target proteins through the proteasome pathway, which displays significant potential for medical value. In this review, we provide a comprehensive overview of the development history and the reported mechanism of action of HyTTDs. Additionally, we delve into the physiological roles, structure-activity relationships, and medical implications of HyTTDs targeting various disease-associated proteins. Moreover, we propose insights into the challenges that necessitate resolution for the successful development of HyTTDs, with the ultimate goal of initiating a new age of clinical treatment leveraging the immense potential of HyTTDs.
- Targeted protein degradation (TPD),
- Hydrophobic tag,
- Degrader,
- Hydrophobic tag tethering degrader (HyTTD),
- Targeted therapy
1. [1]
  T.K. Neklesa, J.D. Winkler, C.M. Crews, Pharmacol. Ther. 174 (2017) 138–144. doi: 10.1016/j.pharmthera.2017.02.027
2. [2]
  A.J. Tao, G.E. Gadbois, S.A. Buczynski, et al., Curr. Opin. Chem. Biol. 67 (2022) 102114. doi: 10.1016/j.cbpa.2021.102114
3. [3]
  M.P. Kannan, S. Sreeraman, C.S. Somala, et al., Fut. Med. Chem. 15 (2023) 867–883. doi: 10.4155/fmc-2023-0072
4. [4]
  M.H. Glickman, A. Ciechanover, Physiol. Rev. 82 (2002) 373–428. doi: 10.1152/physrev.00027.2001
5. [5]
  K. Cassidy, H. Zhao, Biochemistry 62 (2023) 580–587. doi: 10.1021/acs.biochem.1c00330
6. [6]
  L.M. Luh, U. Scheib, K. Juenemann, et al., Angew. Chem. Int. Ed. 59 (2020) 15448–15466. doi: 10.1002/anie.202004310
7. [7]
  X. Li, Y.C. Song, J. Hematol. Oncol. 13 (2020) 50. doi: 10.1002/jeq2.20016
8. [8]
  Y.H. Sun, X. Luo, Z.M. Yang, et al., Chin. Chem. Lett. 34 (2023) 107924. doi: 10.1016/j.cclet.2022.107924
9. [9]
  M. He, C.G. Cao, Z.H. Ni, et al., Signal Transduct. Target. Ther. 7 (2022) 181. doi: 10.1038/s41392-022-00999-9
10. [10]
  A.P. Chen, Y. Zhong, Y.X. Liu, et al., Chin. Chem. Lett. 34 (2023) 107923. doi: 10.1016/j.cclet.2022.107923
11. [11]
  C.L. Pu, S.R. Wang, L. Liu, et al., Chin. Chem. Lett. 34 (2023) 107927. doi: 10.1016/j.cclet.2022.107927
12. [12]
  Z.Y. Hu, C.M. Crews, ChemBioChem 23 (2022) e202100270. doi: 10.1002/cbic.202100270
13. [13]
  K. Li, C.M. Crews, Chem. Soc. Rev. 51 (2022) 5214–5236. doi: 10.1039/d2cs00193d
14. [14]
  M. Bekes, D.R. Langley, C.M. Crews, Nat. Rev. Drug Discov. 21 (2022) 181–200. doi: 10.1038/s41573-021-00371-6
15. [15]
  G. Ahn, S.M. Banik, C.L. Miller, et al., Nat. Chem. Biol. 17 (2021) 937–946. doi: 10.1038/s41589-021-00770-1
16. [16]
  K. Wang, A.L. Yu, K.W. Liu, et al., Adv. Sci. 10 (2023) 2300288. doi: 10.1002/advs.202300288
17. [17]
  A.D. Cotton, D.P. Nguyen, J.A. Gramespacher, et al., J. Am. Chem. Soc. 143 (2021) 593–598. doi: 10.1021/jacs.0c10008
18. [18]
  D. Takahashi, J. Moriyama, T. Nakamura, et al., Mol. Cell 76 (2019) 797–810. doi: 10.1016/j.molcel.2019.09.009
19. [19]
  Z.Y. Li, C.G. Zhu, Y. Ding, et al., Autophagy 16 (2020) 185–187. doi: 10.1080/15548627.2019.1688556
20. [20]
  L. Zhao, J. Zhao, K.H. Zhong, et al., Signal Transduct. Target. Ther. 7 (2022) 113. doi: 10.1007/978-981-16-9515-5_9
21. [21]
  G.Q. Dong, Y. Ding, S.P. He, et al., J. Med. Chem. 64 (2021) 10606–10620. doi: 10.1021/acs.jmedchem.1c00895
22. [22]
  J.K. Gao, J.T. Zhang, X.L. Han, et al., Curr. Med. Chem. 30 (2023) 3137–3155. doi: 10.2174/0929867329666220930120328
23. [23]
  S.W. Xie, F.Y. Zhan, J.J. Zhu, et al., Angew. Chem. Int. Ed. 135 (2023) e202217246. doi: 10.1002/ange.202217246
24. [24]
  Y. Asawa, K. Nishida, K. Kawai, et al., Bioconjug. Chem. 32 (2021) 2377–2385. doi: 10.1021/acs.bioconjchem.1c00431
25. [25]
  K. Hirai, H. Yamashita, S. Tomoshige, et al., ACS Med. Chem. Lett. 13 (2022) 396–402. doi: 10.1021/acsmedchemlett.1c00500
26. [26]
  J.C. Li, T. Liu, Y.L. Song, et al., J. Med. Chem. 65 (2022) 11034–11057. doi: 10.1021/acs.jmedchem.2c00257
27. [27]
  H.K. Patel, T. Bihani, Pharmacol. Ther. 186 (2018) 1–24. doi: 10.1016/j.pharmthera.2017.12.012
28. [28]
  H.S. Tae, T.B. Sundberg, T.K. Neklesa, et al. ChemBioChem 13 (2012) 538–541. doi: 10.1002/cbic.201100793
29. [29]
  T.K. Neklesa, D.J. Noblin, A.P. Kuzin, et al. ACS Chem. Biol. 8 (2013) 2293–2300. doi: 10.1021/cb400569k
30. [30]
  T. Xie, S.M. Lim, K.D. Westover, et al., Nat. Chem. Biol. 10 (2014) 1006–1012. doi: 10.1038/nchembio.1658
31. [31]
  G.E. Karagöz, D. Acosta-Alvear, P. Walter, Cold Spring Harbor Perspect. Biol. 11 (2019) a033886. doi: 10.1101/cshperspect.a033886
32. [32]
  A.C. Lai, C.M. Crews, Nat. Rev. Drug Discov. 16 (2017) 101–114. doi: 10.1038/nrd.2016.211
33. [33]
  Y. Shi, M.J.C. Long, M.M. Rosenberg, et al., ACS Chem. Biol. 11 (2016) 3328–3337. doi: 10.1021/acschembio.6b00656
34. [34]
  R.P. Hanley, D.Y. Nie, J.R. Tabor, et al., J. Am. Chem. Soc. 145 (2023) 8176–8188. doi: 10.1021/jacs.3c01421
35. [35]
  R.K. Rej, J.E. Thomas, R.K. Acharyya, et al., J. Med. Chem. 66 (2023) 8339–8381. doi: 10.1021/acs.jmedchem.3c00136
36. [36]
  L. Wang, A. Sharma, Chem. Med. Chem. 15 (2020) 2072–2097. doi: 10.1002/cmdc.202000473
37. [37]
  X. Lin, H. Xiang, G.S. Luo, Eur. J. Med. Chem. 206 (2020) 112689. doi: 10.1016/j.ejmech.2020.112689
38. [38]
  S. Arnesen, Z. Blanchard, M.M. Williams, et al. Cancer Res. 81 (2021) 539–551. doi: 10.1158/0008-5472.can-20-1171
39. [39]
  A.E. Wakeling, J. Bowler, J. Endocrinol. 112 (1987) R7–R10. doi: 10.1677/joe.0.112R007
40. [40]
  L. Wang, A. Sharma, Chem. Soc. Rev. 51 (2022) 8149–8159. doi: 10.1039/d2cs00117a
41. [41]
  B.M. Wittmann, A. Sherk, D.P. McDonnell, Cancer Res. 67 (2007) 9549–9560. doi: 10.1158/0008-5472.CAN-07-1590
42. [42]
  T. Downton, F.A. Zhou, D. Segara, et al., Drug Des. Dev. Ther. 16 (2022) 2933–2948. doi: 10.2147/dddt.s380925
43. [43]
  M. Mottamal, B.R. Kang, X.Y. Peng, et al., ACS Omega 6 (2021) 9334–9343. doi: 10.1021/acsomega.0c06362
44. [44]
  F.C. Bidard, V.G. Kaklamani, P. Neven, et al., J. Clin. Oncol. 40 (2022) 3246–3256. doi: 10.1200/jco.22.00338
45. [45]
  Y.Y. Li, S.L. Zhang, J. Zhang, et al., Eur. J. Med. Chem. 172 (2019) 48–61. doi: 10.1016/j.ejmech.2019.03.058
46. [46]
  Y. Zhao, C.X. Zhao, J. Lu, et al., Pharmacol. Res. 146 (2019) 104294. doi: 10.1016/j.phrs.2019.104294
47. [47]
  J.J. Liang, W.L. Yu, L. Yang, et al., Eur. J. Med. Chem. 229 (2022) 114081. doi: 10.1016/j.ejmech.2021.114081
48. [48]
  J.D. Hayes, J.U. Flanagan, I.R. Jowsey, Annu. Rev. Pharmacol. Toxicol. 45 (2005) 51–88. doi: 10.1146/annurev.pharmtox.45.120403.095857
49. [49]
  V. Adler, Z.M. Yin, S.Y. Fuchs, et al., EMBO J. 18 (1999) 1321–1334. doi: 10.1093/emboj/18.5.1321
50. [50]
  J. Ploemen, B. Vanommen, J.J.P. Bogaards, et al., Xenobiotica 23 (1993) 913–923. doi: 10.3109/00498259309059418
51. [51]
  G. Ricci, F. De Maria, G. Antonini, et al., J. Biol. Chem. 280 (2005) 26397–26405. doi: 10.1074/jbc.M503295200
52. [52]
  M.J.C. Long, D.R. Gollapalli, L. Hedstrom, Chem. Biol. 19 (2012) 629–637. doi: 10.1016/j.chembiol.2012.04.008
53. [53]
  X.N. Li, Z.R. Lu, C. Wang, et al., ACS Med. Chem. Lett. 12 (2021) 720–725. doi: 10.1021/acsmedchemlett.0c00627
54. [54]
  R. Mishra, H. Patel, S. Alanazi, et al., Oncol. Rev. 12 (2018) 45–62.
55. [55]
  N. Jura, Y.B. Shan, X.X. Cao, et al., Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 21608–21613. doi: 10.1073/pnas.0912101106
56. [56]
  M.J. Niederst, H.C. Hu, H.E. Mulvey, et al., Clin. Cancer Res. 21 (2015) 3924–3933. doi: 10.1158/1078-0432.CCR-15-0560
57. [57]
  K.S. Thress, C.P. Paweletz, E. Felip, et al., Nat. Med. 21 (2015) 560–562. doi: 10.1038/nm.3854
58. [58]
  C. Stottrup, T. Tsang, Y.R. Chin, Mol. Cancer Ther. 15 (2016) 1964–1974. doi: 10.1158/1535-7163.MCT-15-0748
59. [59]
  J. Levenga, H. Wong, R.A. Milstead, et al., eLife 6 (2017) e30640. doi: 10.7554/eLife.30640
60. [60]
  F. Xu, X. Zhang, Z.P. Chen, et al., J. Med. Chem. 65 (2022) 14032–14048. doi: 10.1021/acs.jmedchem.2c01246
61. [61]
  J.D. Joseph, N. Lu, J. Qian, et al., Cancer Discov. 3 (2013) 1020–1029. doi: 10.1158/2159-8290.CD-13-0226
62. [62]
  R.R. McKay, L. Kwak, J.P. Crowdis, et al., Clin. Cancer Res. 27 (2021) 3610–3619. doi: 10.1158/1078-0432.ccr-20-4616
63. [63]
  A.W. Wyatt, M. Annala, R. Aggarwal, et al., J. Natl. Cancer Inst. 110 (2017) djx118.
64. [64]
  G.N. Brooke, C.L. Bevan, Curr. Genom. 10 (2009) 18–25. doi: 10.2174/138920209787581307
65. [65]
  M.D. Balbas, M.J. Evans, D.J. Hosfield, et al., eLife 2 (2013) e00499. doi: 10.7554/eLife.00499
66. [66]
  S. Prekovic, T. Van den Broeck, S. Linder, et al. Endocr. Relat. Cancer 25 (2018) R545–R557. doi: 10.1530/erc-17-0136
67. [67]
  S.R. Viswanathan, G. Ha, A.M. Hoff, et al. Cell 174 (2018) 433–447. doi: 10.1016/j.cell.2018.05.036
68. [68]
  S. Ha, G.S. Luo, H. Xiang, J. Med. Chem. 65 (2022) 16128–16154. doi: 10.1021/acs.jmedchem.2c01487
69. [69]
  J.L. Gustafson, T.K. Neklesa, C.S. Cox, et al. Angew. Chem. Int. Ed. 54 (2015) 9659–9662. doi: 10.1002/anie.201503720
70. [70]
  H. Xie, J.J. Liang, Y.L. Wang, et al., Eur. J. Med. Chem. 204 (2020) 112512. doi: 10.1016/j.ejmech.2020.112512
71. [71]
  M. Bollen, D.W. Gerlich, B. Lesage, Trends Cell Biol. 19 (2009) 531–541. doi: 10.1016/j.tcb.2009.06.005
72. [72]
  K. Strebhardt, A. Ullrich, Nat. Rev. Cancer 6 (2006) 321–330. doi: 10.1038/nrc1841
73. [73]
  J.P. Yuan, M. Sanhaji, A. Kramer, et al., Am. J. Pathol. 179 (2011) 2091–2099. doi: 10.1016/j.ajpath.2011.06.031
74. [74]
  A. Scharow, M. Raab, K. Saxena, et al., ACS Chem. Biol. 10 (2015) 2570–2579. doi: 10.1021/acschembio.5b00565
75. [75]
  S. Rubner, A. Scharow, S. Schubert, et al., Angew. Chem. Int. Ed. 57 (2018) 17043–17047. doi: 10.1002/anie.201809640
76. [76]
  S. Rubner, S. Schubert, T. Berg, Org. Biomol. Chem. 17 (2019) 3113–3117. doi: 10.1039/c9ob00080a
77. [77]
  D. Hamroun, S. Kato, C. Ishioka, et al., Hum. Mutat. 27 (2006) 14–20. doi: 10.1002/humu.20269
78. [78]
  D. Lane, A. Levine, Cold Spring Harbor Perspect. Biol. 2 (2010) a000893.
79. [79]
  M. Wade, Y.C. Li, G.M. Wahl, Nat. Rev. Cancer 13 (2013) 83–96. doi: 10.1038/nrc3430
80. [80]
  H.J. Li, X.Y. Chen, M.H. Wu, et al., Chin. Chem. Lett. 33 (2022) 1254–1258. doi: 10.1016/j.cclet.2021.08.130
81. [81]
  T. Thompson, C. Tovar, H. Yang, et al., J. Biol. Chem. 279 (2004) 53015–53022. doi: 10.1074/jbc.M410233200
82. [82]
  F. Nietzold, S. Rubner, T. Berg, Chem. Commun. 55 (2019) 14351–14354. doi: 10.1039/c9cc07795b
83. [83]
  T.K. Neklesa, H.S. Tae, A.R. Schneekloth, et al., Nat. Chem. Biol. 7 (2011) 538–543. doi: 10.1038/nchembio.597
84. [84]
  I. Faraoni, G. Graziani, Cancers 10 (2018) 487. doi: 10.3390/cancers10120487
85. [85]
  X.W. Zhang, C.L. Zhang, L. Tang, et al., Chin. Chem. Lett. 31 (2020) 136–140. doi: 10.1016/j.cclet.2019.04.045
86. [86]
  A. Shailani, R.P. Kaur, A. Munshi, Med. Oncol. 35 (2018) 18. doi: 10.1007/s12032-018-1085-8
87. [87]
  K.B. Kuchenbaecker, J.L. Hopper, D.R. Barnes, et al., J. Am. Med. Assoc. 317 (2017) 2402–2416. doi: 10.1001/jama.2017.7112
88. [88]
  H. Farmer, N. McCabe, C.J. Lord, et al., Nature 434 (2005) 917–921. doi: 10.1038/nature03445
89. [89]
  P.C. Fong, T.A. Yap, D.S. Boss, et al., J. Clin. Oncol. 28 (2010) 2512–2519. doi: 10.1200/JCO.2009.26.9589
90. [90]
  A. Go, J.W. Jang, W. Lee, et al., Eur. J. Med. Chem. 204 (2020) 112635. doi: 10.1016/j.ejmech.2020.112635
91. [91]
  R. Margueron, D. Reinberg, Nature 469 (2011) 343–349. doi: 10.1038/nature09784
92. [92]
  A. Kuzmichev, K. Nishioka, H. Erdjument-Bromage, et al., Genes Dev. 16 (2002) 2893–2905. doi: 10.1101/gad.1035902
93. [93]
  K.H. Kim, C.W.M. Roberts, Nat. Med. 22 (2016) 128–134. doi: 10.1038/nm.4036
94. [94]
  S. Varambally, S.M. Dhanasekaran, M. Zhou, et al., Nature 419 (2002) 624–629. doi: 10.1038/nature01075
95. [95]
  C.G. Kleer, Q. Cao, S. Varambally, et al., Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11606–11611. doi: 10.1073/pnas.1933744100
96. [96]
  J. Kim, Y. Lee, X.D. Lu, et al., Cell Rep. 25 (2018) 2808–2820. doi: 10.1016/j.celrep.2018.11.035
97. [97]
  E. Curry, I. Green, N. Chapman-Rothe, et al., Clin. Epigenet. 7 (2015) 84. doi: 10.1186/s13148-015-0118-9
98. [98]
  A.Q. Ma, E. Stratikopoulos, K.S. Park, et al., Nat. Chem. Biol. 16 (2020) 214–222. doi: 10.1038/s41589-019-0421-4
99. [99]
  J.M. Xu, R.C. Wu, B.W. O'Malley, Nat. Rev. Cancer 9 (2009) 615–630. doi: 10.1038/nrc2695
100. [100]
  M. Spears, S. Oesterreich, I. Migliaccio, et al., Breast Cancer Res. Treat. 131 (2012) 463–472. doi: 10.1007/s10549-011-1426-1
101. [101]
  C.A. Walsh, L. Qin, J.C.Y. Tien, et al., Int. J. Biol. Sci. 8 (2012) 470–485. doi: 10.7150/ijbs.4125
102. [102]
  P.M. Cromm, C.M. Crews, Cell Chem. Biol. 24 (2017) 1181–1190. doi: 10.1016/j.chembiol.2017.05.024
103. [103]
  Y. Lee, J. Heo, H. Jeong, et al., Angew. Chem. Int. Ed. 59 (2020) 17548–17555. doi: 10.1002/anie.202005004
104. [104]
  S.R. Choi, H.M. Wang, M.H. Shin, et al., Int. J. Mol. Sci. 22 (2021) 6407. doi: 10.3390/ijms22126407
105. [105]
  P. Gupta, S. Narayanan, D.H. Yang, CDK inhibitors as sensitizing agents for cancer chemotherapy, in: Z.S. Chen, D.H. Yang (Eds.), Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy, Academic Press, New York, 2019, pp. 125–149.
106. [106]
  B. O'Leary, R.S. Finn, N.C. Turner, Nat. Rev. Clin. Oncol. 13 (2016) 417–430. doi: 10.1038/nrclinonc.2016.26
107. [107]
  B. Laderian, T. Fojo, Semin. Oncol. 44 (2017) 395–403. doi: 10.1053/j.seminoncol.2018.03.006
108. [108]
  U.S. Asghar, A.R. Barr, R. Cutts, et al., Clin. Cancer Res. 23 (2017) 5561–5572. doi: 10.1158/1078-0432.CCR-17-0369
109. [109]
  A. Fassl, C. Brain, M. Abu-Remaileh, et al., Sci. Adv. 6 (2020) eabb2210. doi: 10.1126/sciadv.abb2210
110. [110]
  J.H. Qiu, X.F. Bai, W.J. Zhang, et al., Front. Pharmacol. 13 (2022) 853993. doi: 10.3389/fphar.2022.853993
111. [111]
  A.T. Anshabo, R. Milne, S.D. Wang, et al., Front. Oncol. 11 (2021) 678559. doi: 10.3389/fonc.2021.678559
112. [112]
  R. Mandal, S. Becker, K. Strebhardt, Cancers 13 (2021) 2181. doi: 10.3390/cancers13092181
113. [113]
  C.H. Huang, A. Lujambio, J. Zuber, et al., Genes Dev. 28 (2014) 1800–1814. doi: 10.1101/gad.244368.114
114. [114]
  A. Richters, S.K. Doyle, D.B. Freeman, et al., Cell Chem. Biol. 28 (2021) 134–147. doi: 10.1016/j.chembiol.2020.10.001
115. [115]
  E.A. Musgrove, C.E. Caldon, J. Barraclough, et al., Nat. Rev. Cancer 11 (2011) 558–572. doi: 10.1038/nrc3090
116. [116]
  T.Z. Wu, Z. Qin, Y.C. Tian, et al., J. Med. Chem. 63 (2020) 13228–13257. doi: 10.1021/acs.jmedchem.0c00744
117. [117]
  C. Sanchez-Martinez, M.J. Lallena, S.G. Sanfeliciano, et al., Bioorg. Med. Chem. Lett. 29 (2019) 126637. doi: 10.1016/j.bmcl.2019.126637
118. [118]
  C.M. Olson, B.S. Jiang, M.A. Erb, et al., Nat. Chem. Biol. 14 (2018) 163–170. doi: 10.1038/nchembio.2538
119. [119]
  X.Q. Qiu, Y.Q. Li, B. Yu, et al., Eur. J. Med. Chem. 211 (2021) 113091. doi: 10.1016/j.ejmech.2020.113091
120. [120]
  B.L. Allen, D.J. Taatjes, Nat. Rev. Mol. Cell Biol. 16 (2015) 155–166. doi: 10.1038/nrm3951
121. [121]
  Nitulescu, I.I., S.C. Meyer, Q.J. Wen, et al., EBioMedicine 26 (2017) 112–125. doi: 10.1016/j.ebiom.2017.11.013
122. [122]
  D.C. Porter, E. Farmaki, S. Altilia, et al., Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 13799–13804. doi: 10.1073/pnas.1206906109
123. [123]
  M.Q. Chen, J.X. Liang, H. Ji, et al., Proc. Natl. Acad. Sci. U. S. A. 114 (2017) 10208–10213. doi: 10.1073/pnas.1710467114
124. [124]
  D.Z. Xu, C.F. Li, X. Zhang, et al., Nat. Commun. 6 (2015) 6641. doi: 10.1038/ncomms7641
125. [125]
  J. Bragelmann, N. Klumper, A. Offermann, et al., Clin. Cancer Res. 23 (2017) 1829–1840. doi: 10.1158/1078-0432.CCR-16-0094
126. [126]
  J.X. Liang, M.Q. Chen, D. Hughes, et al., Cancer Res. 78 (2018) 6594–6606. doi: 10.1158/0008-5472.can-18-1583
127. [127]
  M.Q. Chen, J. Li, J.X. Liang, et al., Cells 8 (2019) 1413. doi: 10.3390/cells8111413
128. [128]
  I. Menzl, T.H. Zhang, A. Berger-Becvar, et al., Nat. Commun. 10 (2019) 4741. doi: 10.1038/s41467-019-12656-x
129. [129]
  M.Y. Wang, R.K. Lin, J.C. Li, et al., J. Med. Chem. 66 (2023) 4932–4951. doi: 10.1021/acs.jmedchem.2c02045
130. [130]
  A.D. Cox, S.W. Fesik, A.C. Kimmelman, et al., Nat. Rev. Drug Discov. 13 (2014) 828–851. doi: 10.1038/nrd4389
131. [131]
  J. Hu, P.C. Zhu, Y.M. Li, et al., Chin. Chem. Lett. 29 (2018) 1043–1050. doi: 10.1016/j.cclet.2018.05.035
132. [132]
  J.L. Bos, H. Rehmann, A. Wittinghofer, Cell 129 (2007) 865–877. doi: 10.1016/j.cell.2007.05.018
133. [133]
  F.Q. Chen, M.P. Alphonse, Y. Liu, et al., Curr. Top. Med. Chem. 19 (2019) 2098–2113. doi: 10.2174/1568026619666190902151307
134. [134]
  P. Martin-Gago, E.K. Fansa, C.H. Klein, et al., Angew. Chem. Int. Ed. 56 (2017) 2423–2428. doi: 10.1002/anie.201610957
135. [135]
  P. Martin-Gago, E.K. Fansa, A. Wittinghofer, et al., Biol. Chem. 398 (2017) 535–545. doi: 10.1515/hsz-2016-0272
136. [136]
  M.L. Guo, S.P. He, J.F. Cheng, et al., ACS Med. Chem. Lett. 13 (2022) 298–303. doi: 10.1021/acsmedchemlett.1c00670
137. [137]
  R.H. Palmer, E. Vernersson, C. Grabbe, et al., Biochem. J. 420 (2009) 345–361. doi: 10.1042/BJ20090387
138. [138]
  M. Soda, Y.L. Choi, M. Enomoto, et al., Nature 448 (2007) 561–566. doi: 10.1038/nature05945
139. [139]
  C.M. Coffin, A. Patel, S. Perkins, et al., Mod. Pathol. 14 (2001) 569–576. doi: 10.1038/modpathol.3880352
140. [140]
  R.D. Gascoyne, L. Lamant, J.I. Martin-Subero, et al. Blood 102 (2003) 2568–2573. doi: 10.1182/blood-2003-03-0786
141. [141]
  T. Iwahara, J. Fujimoto, D.Z. Wen, et al., Oncogene 14 (1997) 439–449. doi: 10.1038/sj.onc.1200849
142. [142]
  X.T. Kong, P.C. Pan, H.Y. Sun, et al., J. Med. Chem. 62 (2019) 10927–10954. doi: 10.1021/acs.jmedchem.9b00446
143. [143]
  S.W. Xie, Y. Sun, Y.L. Liu, et al., J. Med. Chem. 64 (2021) 9120–9140. doi: 10.1021/acs.jmedchem.1c00270
144. [144]
  A.J. Kuo, P. Cheung, K.F. Chen, et al., Mol. Cell 44 (2011) 609–620. doi: 10.1016/j.molcel.2011.08.042
145. [145]
  D. Sengupta, L.Y. Zeng, Y.M. Li, et al., Mol. Cell 81 (2021) 4481–4492. doi: 10.1016/j.molcel.2021.08.034
146. [146]
  S. Yuan, R. Natesan, F.J. Sanchez-Rivera, et al., Cancer Discov. 10 (2020) 854–871. doi: 10.1158/2159-8290.cd-19-1299
147. [147]
  N.P. Coussens, S.C. Kales, M.J. Henderson, et al., J. Biol. Chem. 293 (2018) 13750–13765. doi: 10.1074/jbc.ra118.004274
148. [148]
  D. Dilworth, R.P. Hanley, R.F. de Freitas, et al., Nat. Chem. Biol. 18 (2022) 56–63. doi: 10.1038/s41589-021-00898-0
149. [149]
  J.H. Bushweller, Nat. Rev. Cancer 19 (2019) 611–624. doi: 10.1038/s41568-019-0196-7
150. [150]
  M. Schapira, M.F. Calabrese, A.N. Bullock, et al., Nat. Rev. Drug Discov. 18 (2019) 949–963. doi: 10.1038/s41573-019-0047-y
151. [151]
  T. Tamura, I. Hamachi, J. Am. Chem. Soc. 141 (2019) 2782–2799. doi: 10.1021/jacs.8b11747
152. [152]
  Y. Wang, J. Zhang, J. Deng, et al., CCS Chem. 5 (2023) 2207–2214. doi: 10.31635/ccschem.023.202302873
153. [153]
  W.K. Jin, H.D. Tan, J.H. Wu, et al., Drug Discov. Today 27 (2022) 246–256. doi: 10.1016/j.drudis.2021.08.007
154. [154]
  C. -Y. Yang, C. Qin, L. Bai, et al., Drug Discov. Today: Technol. 31 (2019) 43–51. doi: 10.1016/j.ddtec.2019.04.001
155. [155]
  P. Filippakopoulos, J. Qi, S. Picaud, et al., Nature 468 (2010) 1067–1073. doi: 10.1038/nature09504
156. [156]
  J. Balzeau, M.R. Menezes, S.Y. Cao, et al., Front. Genet. 8 (2017) 31.
157. [157]
  A. Ghidini, A. Clery, F. Halloy, et al., Angew. Chem. Int. Ed. 60 (2021) 3163–3169. doi: 10.1002/anie.202012330
158. [158]
  C. Ballatore, V.M.Y. Lee, J.Q. Trojanowski, Nat. Rev. Neurosci. 8 (2007) 663–672. doi: 10.1038/nrn2194
159. [159]
  K.A. Vossel, K. Zhang, J. Brodbeck, et al., Science 330 (2010) 198. doi: 10.1126/science.1194653
160. [160]
  L.M. Ittner, Y.D. Ke, F. Delerue, et al., Cell 142 (2010) 387–397. doi: 10.1016/j.cell.2010.06.036
161. [161]
  D. Bumcrot, M. Manoharan, V. Koteliansky, et al. Nat. Chem. Biol. 2 (2006) 711–719. doi: 10.1038/nchembio839
162. [162]
  N. Gao, T.T. Chu, Q.Q. Li, et al., RSC Adv. 7 (2017) 40362–40366. doi: 10.1039/C7RA05347A
163. [163]
  C.F. Sephton, B. Cenik, B.K. Cenik, et al., Biol. Chem. 393 (2012) 589–594. doi: 10.1515/hsz-2012-0115
164. [164]
  T. Geuens, D. Bouhy, V. Timmerman, Hum. Genet. 135 (2016) 851–867. doi: 10.1007/s00439-016-1683-5
165. [165]
  M. Polymenidou, C. Lagier-Tourenne, K.R. Hutt, et al., Nat. Neurosci. 14 (2011) 459–468. doi: 10.1038/nn.2779
166. [166]
  C.F. Sephton, C. Cenik, A. Kucukural, et al., J. Biol. Chem. 286 (2011) 1204–1215. doi: 10.1074/jbc.M110.190884
167. [167]
  S.J. Barmada, G. Skibinski, E. Korb, et al., J. Neurosci. 30 (2010) 639–649. doi: 10.1523/JNEUROSCI.4988-09.2010
168. [168]
  H. Ederle, D. Dormann, FEBS Lett. 591 (2017) 1489–1507. doi: 10.1002/1873-3468.12646
169. [169]
  H. Wils, G. Kleinberger, J. Janssens, et al., Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 3858–3863. doi: 10.1073/pnas.0912417107
170. [170]
  N. Gao, Y.P. Huang, T.T. Chu, et al., Bioorg. Chem. 84 (2019) 254–259. doi: 10.1016/j.bioorg.2018.11.042
171. [171]
  M.E. Macdonald, C.M. Ambrose, M.P. Duyao, et al., Cell 72 (1993) 971–983. doi: 10.1016/0092-8674(93)90585-E
172. [172]
  G.P. Bates, R. Dorsey, J.F. Gusella, et al., Nat. Rev. Dis. Primers 1 (2015) 15005. doi: 10.1038/nrdp.2015.5
173. [173]
  C.A. Ross, S.J. Tabrizi, Lancet Neurol. 10 (2011) 83–98. doi: 10.1016/S1474-4422(10)70245-3
174. [174]
  F. Saudou, S. Humbert, Neuron 89 (2016) 910–926. doi: 10.1016/j.neuron.2016.02.003
175. [175]
  B. Boland, W.H. Yu, O. Corti, et al., Nat. Rev. Drug Discov. 17 (2018) 660–688. doi: 10.1038/nrd.2018.109
176. [176]
  J.J. Hu, Y.F. Zhao, Y.M. Li, Chin. Chem. Lett. 34 (2023) 107623. doi: 10.1016/j.cclet.2022.06.046
177. [177]
  S. Tomoshige, S. Nomura, K. Ohgane, et al., Angew. Chem. Int. Ed. 56 (2017) 11530–11533. doi: 10.1002/anie.201706529
178. [178]
  E.M. Roth, M.H. Davidson, Rev. Cardiovasc. Med. 19 (2018) S31–S46.
179. [179]
  N.G. Seidah, A. Prat, A. Pirillo, et al., Cardiovasc. Res. 115 (2019) 510–518. doi: 10.1093/cvr/cvz003
180. [180]
  H.J. Kwon, T.A. Lagace, M.C. McNutt, et al., Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 1820–1825. doi: 10.1073/pnas.0712064105
181. [181]
  W.L. Petrilli, G.C. Adam, R.S. Erdmann, et al., Cell Chem. Biol. 27 (2020) 32–40. doi: 10.1016/j.chembiol.2019.10.002
182. [182]
  T.S. Fisher, P. Lo Surdo, S. Pandit, et al., J. Biol. Chem. 282 (2007) 20502–20512. doi: 10.1074/jbc.M701634200
183. [183]
  M. Naito, N. Ohoka, N. Shibata, et al., Front. Chem. 7 (2019) 849. doi: 10.3389/fchem.2019.00849
1. [1]
  Yang Liu , Yan Liu , Kaiyin Yang , Zhiruo Zhang , Wenbo Zhang , Bingyou Yang , Hua Li , Lixia Chen . A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2. Chinese Chemical Letters, 2024, 35(8): 109264-. doi: 10.1016/j.cclet.2023.109264
2. [2]
  Yang Liu , Jing Liang , Mengzhu Zheng , Haoze Song , Lixia Chen , Hua Li . PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity. Chinese Chemical Letters, 2025, 36(6): 110317-. doi: 10.1016/j.cclet.2024.110317
3. [3]
  Menglu Guo , Ying-Qi Song , Junfei Cheng , Guoqiang Dong , Xun Sun , Chunquan Sheng . Hydrophobic tagging-induced degradation of NAMPT in leukemia cells. Chinese Chemical Letters, 2024, 35(9): 109392-. doi: 10.1016/j.cclet.2023.109392
4. [4]
  Chao Zhang , Ai-Feng Liu , Shihui Li , Fang-Yuan Chen , Jun-Tao Zhang , Fang-Xing Zeng , Hui-Chuan Feng , Ping Wang , Wen-Chao Geng , Chuan-Rui Ma , Dong-Sheng Guo . A supramolecular formulation of icariin@sulfonatoazocalixarene for hypoxia-targeted osteoarthritis therapy. Chinese Chemical Letters, 2025, 36(1): 109752-. doi: 10.1016/j.cclet.2024.109752
5. [5]
  Yueying Yang , Huiru Xie , Xinbo Yu , Yang Liu , Hui Wang , Hua Li , Lixia Chen . Design, synthesis and evaluation of the first DYRK1A degrader for promoting the proliferation of pancreatic β-cells. Chinese Chemical Letters, 2024, 35(11): 109570-. doi: 10.1016/j.cclet.2024.109570
6. [6]
  Zixu Xie , Pengfei Zhang , Ziyao Zhang , Chen Chen , Xing Wang . The choice of antimicrobial polymers: Hydrophilic or hydrophobic?. Chinese Chemical Letters, 2024, 35(9): 109768-. doi: 10.1016/j.cclet.2024.109768
7. [7]
  Hao Cai , Xiaoyan Wu , Lei Jiang , Feng Yu , Yuxiang Yang , Yan Li , Xian Zhang , Jian Liu , Zijian Li , Hong Bi . Lysosome-targeted carbon dots with a light-controlled nitric oxide releasing property for enhanced photodynamic therapy. Chinese Chemical Letters, 2024, 35(4): 108946-. doi: 10.1016/j.cclet.2023.108946
8. [8]
  Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
9. [9]
  Junfei Yang , Ke Wang , Shuxin Sun , Tianqi Pei , Junxiu Li , Xunwei Gong , Cuixia Zheng , Yun Zhang , Qingling Song , Lei Wang . A "spore-like" oral nanodrug delivery platform for precision targeted therapy of inflammatory bowel disease. Chinese Chemical Letters, 2025, 36(3): 110180-. doi: 10.1016/j.cclet.2024.110180
10. [10]
  Yu-Hui Zhang , Ye Tian , Xianliang Sheng , Chen-Shuang Liu , Lu-Qiang Wei , Jie Wang , Yong Chen . Construction of a black phosphorous-based noncovalent multiple nanosupramolecular assembly for synergistic targeted photothermal and chemodynamic therapy. Chinese Chemical Letters, 2025, 36(4): 110193-. doi: 10.1016/j.cclet.2024.110193
11. [11]
  Shangqian Zhang , Jiaxuan Li , Xuan Hu , Zelong Chen , Junliang Dong , Chenhao Hu , Shuang Chao , Yinghua Lv , Yuxin Pei , Zhichao Pei . H₂S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis. Chinese Chemical Letters, 2025, 36(1): 110314-. doi: 10.1016/j.cclet.2024.110314
12. [12]
  Lei Zhang , Chenyang Kou , Kun Ni , Yiwen Chen , Tongchuan Zhang , Baoliang Zhang . Microenvironment regulation of copper sites by chelating hydrophobic polymer for electrosynthesis of ethylene. Chinese Chemical Letters, 2025, 36(6): 110836-. doi: 10.1016/j.cclet.2025.110836
13. [13]
  Botao QU , Qian WANG , Xiaogang NING , Yuxin ZHOU , Ruiping ZHANG . Deeply penetrating photoacoustic imaging in tumor tissues based on dual-targeted melanin nanoparticle. Chinese Journal of Inorganic Chemistry, 2024, 40(5): 1025-1032. doi: 10.11862/CJIC.20230416
14. [14]
  Kun-Heng Li , Hong-Yang Zhao , Dan-Dan Wang , Ming-Hui Qi , Zi-Jian Xu , Jia-Mi Li , Zhi-Li Zhang , Shi-Wen Huang . Mitochondria-targeted nano-AIEgens as a powerful inducer for evoking immunogenic cell death. Chinese Chemical Letters, 2024, 35(5): 108882-. doi: 10.1016/j.cclet.2023.108882
15. [15]
  Bin Fang , Jiaqi Yang , Limin Wang , Haoqin Li , Jiaying Guo , Jiaxin Zhang , Qingyuan Guo , Bo Peng , Kedi Liu , Miaomiao Xi , Hua Bai , Li Fu , Lin Li . A mitochondria-targeted H₂S-activatable fluorogenic probe for tracking hepatic ischemia-reperfusion injury. Chinese Chemical Letters, 2024, 35(6): 108913-. doi: 10.1016/j.cclet.2023.108913
16. [16]
  Yiqiao Chen , Ao Liu , Biwen Yang , Zhenzhen Li , Binggang Ye , Zhouyi Guo , Zhiming Liu , Haolin Chen . Photoluminescence and photothermal conversion in boric acid derived carbon dots for targeted microbial theranostics. Chinese Chemical Letters, 2024, 35(9): 109295-. doi: 10.1016/j.cclet.2023.109295
17. [17]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
18. [18]
  Huamei Zhang , Jingjing Liu , Mingyue Li , Shida Ma , Xucong Zhou , Aixia Meng , Weina Han , Jin Zhou . Imaging polarity changes in pneumonia and lung cancer using a lipid droplet-targeted near-infrared fluorescent probe. Chinese Chemical Letters, 2024, 35(12): 110020-. doi: 10.1016/j.cclet.2024.110020
19. [19]
  Yunkang Tong , Haiqiao Huang , Haolan Li , Mingle Li , Wen Sun , Jianjun Du , Jiangli Fan , Lei Wang , Bin Liu , Xiaoqiang Chen , Xiaojun Peng . Cooperative bond scission by HRP/H₂O₂ for targeted prodrug activation. Chinese Chemical Letters, 2024, 35(12): 109663-. doi: 10.1016/j.cclet.2024.109663
20. [20]
  Fan Zheng , Runsha Xiao , Shuai Huang , Zhikang Chen , Chen Lai , Anyao Bi , Heying Yao , Xueping Feng , Zihua Chen , Wenbin Zeng . Accurate visualization colorectal cancer by monitoring viscosity variations with a novel mitochondria-targeted fluorescent probe. Chinese Chemical Letters, 2025, 36(2): 109876-. doi: 10.1016/j.cclet.2024.109876

Get Citation

PDF

XML

Metrics

PDF Downloads(10)
Abstract views(1667)
HTML views(65)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142